{"mainPropery":{"diseaseId":6309,"diseaseName":"Eales disease","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6309/eales-disease","synonyms":["Idiopathic obliterative vasculopathy","Idiopathic recurrent vitreal hemorrhage"],"synonyms-with-source":[{"name":"Idiopathic obliterative vasculopathy"},{"name":"Idiopathic recurrent vitreal hemorrhage"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"40923"},{"identifierType":"UMLS","identifierId":"C0271073"}]},"diseaseCategories":[{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=Eales%5BTitle%5D%20AND%20disease%5BTitle%5D%20AND%20hasabstract%5Btext%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Eales disease. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Eales+disease%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Eales disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/859/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1225636-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=40923' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1564,"resourceId":2180,"resourceName":"National Eye Institute","descriptionText":"The <a href='http://www.nei.nih.gov/' target='_blank'>National Eye Institute</a> (NEI) provides more information on this topic. You can reach them by calling 301-496-5248 or by E-mail at 2020@nei.nih.gov","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:40923' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":3874,"questionText":"What is Eales disease?","answerText":"<strong>Eales disease</strong> is a rare vision disorder that appears as an inflammation and white haze around the outercoat of the veins in the retina. This condition&nbsp;is most&nbsp;common among young males and normally affects both eyes. In most cases, vision&nbsp;becomes suddenly blurred because the vitreous, the clear jelly that fills the eyeball behind the lens of the eye, seeps out.&nbsp;Treatment&nbsp;includes corticosteroids in the inflammation stage and photocoagulation in the proliferative stage of the disease.[2805] Visual prognosis is good if treatment&nbsp;begins&nbsp;early in the course of the disease.[2806]&nbsp; ","dateModified":"2011-06-13T12:51:00"},"basicQuestions":[{"questionId":4647,"questionText":"How might Eales disease be treated?","answerText":"Depending on the disease stage, treatment may involve <a href=\"http://my.clevelandclinic.org/drugs/corticosteroids/hic_corticosteroids.aspx\" target=_blank>corticosteroids</a> (systemic or periocular) and/or immunosuppressants (<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682167.html\" target=_blank>azathioprine</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html\" target=_blank>cyclosporine</a>).[3610][3611] Anti-tubercular therapy has been&nbsp;recommended by some authors, however this treatment remains controversial.[3610] <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607001.html\" target=_blank>Bevacizumab</a> (Avastin), a monoclonal antibody, is sometimes used via intravitreal injection. This medication appears to induce regression of neovascularization.[3611] Laser photocoagulation&nbsp;has become the treatment of choice in patients in the&nbsp;proliferative stage of Eales disease.&nbsp;Vitreoretinal surgery may be required if recurrent vitreous hemorrhage occurs.[3610][3611] \r\n<p>There may be other treatment options (for example, antioxidant vitamins A, C, and E) for Eales disease as well.[3611] We recommend that you discuss these and other treatment options with your partner's health-care providers.</p>\r\n<p>You can find relevant articles on&nbsp;the treatment of Eales disease&nbsp;through PubMed, a searchable database of biomedical journal articles. Although not all of the articles are available for free online, most articles listed in PubMed have a summary available.&nbsp;To obtain the full article, contact a medical/university library or your local library for interlibrary loan. You can also order articles online through the publisherâ€™s Web site. Using 'Eales disease AND treatment' as your search term should help you locate articles. Use the advanced search feature to narrow your search results. <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?term=Eales%20disease%20AND%20treatment\" target=_blank>Click here</a> to view a search.<br></font><a href=\"http://www.ncbi.nlm.nih.gov/PubMed\" target=_blank><font color=#810081>http://www.ncbi.nlm.nih.gov/PubMed</font></a></p>\r\n<p>The National Library of Medicine (NLM) Web site has a page for locating&nbsp;libraries in your area that can provide direct access to these journals (print or online). The Web page also&nbsp;describes how you can get these articles through interlibrary loan and Loansome Doc (an NLM document-ordering service). You can access this page at the following link </font><a href=\"http://nnlm.gov/members/\" target=_blank><color=#800080>http://nnlm.gov/members/</font></a>. You can also contact the NLM toll-free at 888-346-3656 to locate libraries in your area.</p>","dateModified":"2011-06-13T13:19:00","resourceClassificationName":"Treatment","references":[{"referenceId":3610,"authors":"","articleTitle":"Eales disease","bookWebsiteJournalTitle":"Orphanet","date":"2003","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=40923","dateAccessed":"2011-06-13T00:00:00"},{"referenceId":3611,"authors":"Roth DB","articleTitle":"Eales Disease","bookWebsiteJournalTitle":"eMedicine","date":"2010","url":"http://emedicine.medscape.com/article/1225636-overview","dateAccessed":"2011-06-13T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":31030,"abbreviatedInquiry":"My partner has been diagnosed with Eales disease. How might this condition be treated?","caseQuestions":[{"questionId":4647,"questionText":"How might Eales disease be treated?","answerText":"Depending on the disease stage, treatment may involve <a href=\"http://my.clevelandclinic.org/drugs/corticosteroids/hic_corticosteroids.aspx\" target=_blank>corticosteroids</a> (systemic or periocular) and/or immunosuppressants (<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682167.html\" target=_blank>azathioprine</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html\" target=_blank>cyclosporine</a>).[3610][3611] Anti-tubercular therapy has been&nbsp;recommended by some authors, however this treatment remains controversial.[3610] <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607001.html\" target=_blank>Bevacizumab</a> (Avastin), a monoclonal antibody, is sometimes used via intravitreal injection. This medication appears to induce regression of neovascularization.[3611] Laser photocoagulation&nbsp;has become the treatment of choice in patients in the&nbsp;proliferative stage of Eales disease.&nbsp;Vitreoretinal surgery may be required if recurrent vitreous hemorrhage occurs.[3610][3611] \r\n<p>There may be other treatment options (for example, antioxidant vitamins A, C, and E) for Eales disease as well.[3611] We recommend that you discuss these and other treatment options with your partner's health-care providers.</p>\r\n<p>You can find relevant articles on&nbsp;the treatment of Eales disease&nbsp;through PubMed, a searchable database of biomedical journal articles. Although not all of the articles are available for free online, most articles listed in PubMed have a summary available.&nbsp;To obtain the full article, contact a medical/university library or your local library for interlibrary loan. You can also order articles online through the publisherâ€™s Web site. Using 'Eales disease AND treatment' as your search term should help you locate articles. Use the advanced search feature to narrow your search results. <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?term=Eales%20disease%20AND%20treatment\" target=_blank>Click here</a> to view a search.<br></font><a href=\"http://www.ncbi.nlm.nih.gov/PubMed\" target=_blank><font color=#810081>http://www.ncbi.nlm.nih.gov/PubMed</font></a></p>\r\n<p>The National Library of Medicine (NLM) Web site has a page for locating&nbsp;libraries in your area that can provide direct access to these journals (print or online). The Web page also&nbsp;describes how you can get these articles through interlibrary loan and Loansome Doc (an NLM document-ordering service). You can access this page at the following link </font><a href=\"http://nnlm.gov/members/\" target=_blank><color=#800080>http://nnlm.gov/members/</font></a>. You can also contact the NLM toll-free at 888-346-3656 to locate libraries in your area.</p>","dateModified":"2011-06-13T13:19:00","resourceClassificationName":"Treatment","references":[{"referenceId":3610,"authors":"","articleTitle":"Eales disease","bookWebsiteJournalTitle":"Orphanet","date":"2003","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=40923","dateAccessed":"2011-06-13T00:00:00"},{"referenceId":3611,"authors":"Roth DB","articleTitle":"Eales Disease","bookWebsiteJournalTitle":"eMedicine","date":"2010","url":"http://emedicine.medscape.com/article/1225636-overview","dateAccessed":"2011-06-13T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Eales_disease"}